Tower Research Capital (TRC)’s Vivani Medical VANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.6K | Sell |
2,597
-405
| -13% | -$506 | ﹤0.01% | 4449 |
|
|
2025
Q4 | $3.69K | Buy |
+3,002
| New | +$4.34K | ﹤0.01% | 4330 |
|
|
2025
Q2 | – | Sell |
-2,807
| Closed | -$2.95K | – | 5584 |
|
|
2025
Q1 | $2.95K | Buy |
2,807
+990
| +54% | +$1.14K | ﹤0.01% | 4483 |
|
|
2024
Q4 | $2.11K | Buy |
1,817
+578
| +47% | +$731 | ﹤0.01% | 4902 |
|
|
2024
Q3 | $1.45K | Sell |
1,239
-12,140
| -91% | -$15.2K | ﹤0.01% | 5153 |
|
|
2024
Q2 | $16.9K | Buy |
13,379
+12,390
| +1,253% | +$21.2K | ﹤0.01% | 3852 |
|
|
2024
Q1 | $1.83K | Sell |
989
-10,324
| -91% | -$15.2K | ﹤0.01% | 5172 |
|
|
2023
Q4 | $11.5K | Buy |
11,313
+3,614
| +47% | +$3.58K | ﹤0.01% | 4122 |
|
|
2023
Q3 | $7.85K | Buy |
+7,699
| New | +$8.47K | ﹤0.01% | 4428 |
|
|
2023
Q2 | – | Sell |
-6,721
| Closed | -$7K | – | 6375 |
|
|
2023
Q1 | $7K | Sell |
6,721
-9,241
| -58% | -$10.3K | ﹤0.01% | 4782 |
|
|
2022
Q4 | $14K | Buy |
15,962
+905
| +6% | +$1.47K | ﹤0.01% | 3545 |
|
|
2022
Q3 | $34K | Sell |
15,057
-513
| -3% | -$2.43K | ﹤0.01% | 3498 |
|
|
2022
Q2 | $95K | Buy |
15,570
+15,504
| +23,491% | +$83.6K | ﹤0.01% | 2341 |
|
|
2022
Q1 | $0 | Sell |
66
-5,393
| -99% | -$22.7K | ﹤0.01% | 6567 |
|
|
2021
Q4 | $27K | Sell |
5,459
-5,064
| -48% | -$37K | ﹤0.01% | 3355 |
|
|
2021
Q3 | $101K | Buy |
+10,523
| New | +$119K | ﹤0.01% | 2397 |
|
|
2021
Q2 | – | Sell |
-1,123
| Closed | -$28K | – | 5864 |
|
|
2021
Q1 | $28K | Sell |
1,123
-11,839
| -91% | -$177K | ﹤0.01% | 3621 |
|
|
2020
Q4 | $73K | Buy |
+12,962
| New | +$45.8K | ﹤0.01% | 2683 |
|
|
2020
Q3 | – | Sell |
-3,242
| Closed | -$10K | – | 5113 |
|
|
2020
Q2 | $10K | Buy |
3,242
+2,057
| +174% | +$7.31K | ﹤0.01% | 4022 |
|
|
2020
Q1 | $4K | Buy |
+1,185
| New | +$15.6K | ﹤0.01% | 2405 |
|
|
2019
Q3 | – | Sell |
-800
| Closed | -$15K | – | 4532 |
|
|
2019
Q2 | $15K | Buy |
800
+451
| +129% | +$9.25K | ﹤0.01% | 2351 |
|
|
2019
Q1 | $7K | Buy |
+349
| New | +$6.8K | ﹤0.01% | 2893 |
|
|
2018
Q1 | – | Sell |
-244
| Closed | -$11K | – | 3865 |
|
|
2017
Q4 | $11K | Sell |
244
-778
| -76% | -$25.8K | ﹤0.01% | 2512 |
|
|
2017
Q3 | $29K | Buy |
1,022
+732
| +252% | +$20.5K | ﹤0.01% | 2478 |
|
|
2017
Q2 | $9K | Sell |
290
-326
| -53% | -$9.22K | ﹤0.01% | 1676 |
|
|
2017
Q1 | $18K | Buy |
616
+244
| +66% | +$9.35K | ﹤0.01% | 1371 |
|
|
2016
Q4 | $18K | Buy |
+372
| New | +$21.2K | ﹤0.01% | 2248 |
|
|
2016
Q3 | – | Sell |
-14
| Closed | -$1K | – | 4483 |
|
|
2016
Q2 | $1K | Buy |
+14
| New | +$1.46K | ﹤0.01% | 4223 |
|
|
2016
Q1 | – | Sell |
-21
| Closed | -$3K | – | 4980 |
|
|
2015
Q4 | $3K | Sell |
21
-223
| -91% | -$32.6K | ﹤0.01% | 3524 |
|
|
2015
Q3 | $35K | Sell |
244
-90
| -27% | -$25K | ﹤0.01% | 1279 |
|
|
2015
Q2 | $110K | Buy |
334
+292
| +695% | +$93.6K | 0.01% | 728 |
|
|
2015
Q1 | $13K | Sell |
42
-5
| -11% | -$1.39K | ﹤0.01% | 2588 |
|
|
2014
Q4 | $12K | Buy |
+47
| New | +$16.4K | ﹤0.01% | 2005 |
|
Other funds holding VANI
VCM
TWM
VFT
MMG
Tower Research Capital (TRC)'s VANI Position: Q1 2026 in Review
Tower Research Capital (TRC) reduced its Vivani Medical (VANI) stake by 13% in Q1 2026, selling an estimated $506 and leaving 2,597 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4449.
Tower Research Capital (TRC) first reported a position in VANI in Q4 2014 and has held it in 33 quarters since. The position peaked at $110K in Q2 2015. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.
- Tower Research Capital (TRC) held 2,597 shares of Vivani Medical worth $2.6K as of Q1 2026.
- Tower Research Capital (TRC) sold 405 Vivani Medical shares in Q1 2026, an estimated $506.
- Vivani Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4449 holding.
- Tower Research Capital (TRC) first reported a position in Vivani Medical in Q4 2014 and has held it in 33 quarters since.
- Tower Research Capital (TRC)'s Vivani Medical position peaked at $110K in Q2 2015.
- 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.